Tarsus Pharmaceuticals, Inc. (TARS) Earnings
|
Expand Research on TARS
| Next EPS Date | 5/7/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +44.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/24 | Q124 | N/A | -$1.21 | N/A | N/A | $17.5M | N/A | N/A | N/A | ||
| 2/27/24 | Q423 | -$1.31 | -$1.38 | +$0.07 | $13.08M | $5.29M | N/A |  | | Details | |
| 11/9/23 | Q323 | -$1.28 | -$1.35 | +$0.07 | $1.9M | $399.6K | N/A | | | Details | |
| 8/2/23 | Q223 | N/A | -$1.04 | N/A | N/A | $1.76M | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | N/A | -$1.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | -$0.95 | N/A | N/A | $5M | N/A | N/A | N/A | ||
| 3/13/23 | Q422 | N/A | -$0.74 | N/A | N/A | $10M | N/A | N/A | N/A | ||
| 11/9/22 | Q322 | -$0.76 | -$0.95 | +$0.19 | $1.24M | $3.13M | N/A | | | Details |
